Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation
Publication
, Conference
Field, ME; Rahman, M; Goldstein, L; Maccioni, S; Srivastava, A; Khanna, R; Piccini, JP; Friedman, DJ
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
2020
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
353 / 354
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Field, M. E., Rahman, M., Goldstein, L., Maccioni, S., Srivastava, A., Khanna, R., … Friedman, D. J. (2020). Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (Vol. 29, pp. 353–354).
Field, Michael E., Motiur Rahman, Laura Goldstein, Sonia Maccioni, Abhishek Srivastava, Rahul Khanna, Jonathan P. Piccini, and Daniel J. Friedman. “Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation.” In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 29:353–54, 2020.
Field ME, Rahman M, Goldstein L, Maccioni S, Srivastava A, Khanna R, et al. Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. In: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 353–4.
Field, Michael E., et al. “Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 29, 2020, pp. 353–54.
Field ME, Rahman M, Goldstein L, Maccioni S, Srivastava A, Khanna R, Piccini JP, Friedman DJ. Long-term healthcare use and cost comparison pre-and-post ablation treatment among patients with heart failure and atrial fibrillation. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2020. p. 353–354.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
EISSN
1099-1557
ISSN
1053-8569
Publication Date
2020
Volume
29
Start / End Page
353 / 354
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences